SIRT1 and metabolic dysfunction-associated steatotic liver disease: Previous studies have demonstrated that hepatocyte-specific SIRT1-knockout mice and SIRT1+/– mice are more prone to suffering from liver steatosis and inflammation than wild-type mice25, 26, suggesting that SIRT1 exerts anti-steatosis and anti-inflammatory activities during the pathogenesis of NAFLD.